MannKind(MNKD) - 2025 FY - Earnings Call Transcript

MannKind (MNKD) FY 2025 Conference February 11, 2025 11:20 AM ET Company Participants Michael Castagna - CEOChristopher Prentiss - Chief Financial Officer Conference Call Participants Andreas Argyrides - Managing Director & Senior Analyst - Biotechnology Andreas Argyrides Great. Good morning, everyone, and welcome to Oppenheimer's thirty fifth annual Healthcare Life Science Conference. My name is Andreas Zagredes. I'm one of the senior biotech analysts at Oppenheimer. And today, I have the pleasure to be jo ...